Access to the Experts
Meet and hear first-hand from industry's most influential minds and leading KOLs.
Upcoming Events
C-level networking, partnering and debate
BioCentury and BayHelix present the East-West BioPharma Summit (Oct. 2-4, 2023, Boston/Cambridge). Along with two additional bonus days of virtual 1x1 meetings (Oct. 5-6, 2023).
For a decade, BioCentury, BayHelix, and McKinsey & Company have brought together a C-level biopharma community to debate, network, and partner.
Join BioCentury, BIA, and special guests on the sidelines of the Jefferies London Healthcare Conference for a CEO and investor event you won't forget. Space is limited.
For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner, and debate critical issues facing the biotech industry today.
The Advantages of a BioCentury Event
Learn, Network, Meet Your Next Investor or Partner.
Hear from industry's most influential minds and leading experts
Gain powerful insight, tangible solutions, and practical advice
Meet emerging new companies selected to present by BioCentury
Access related content hand-picked by BioCentury industry experts
Research presenting companies through BioCentury's BCIQ database
Understand the landscape via exclusive reports and “Scene Setter” presentations
Meet potential partners and investors
Schedule 1x1 meetings with industry peers
Forge lasting relationships
Join the many companies that support BioCentury-BayHelix East-West Biopharma Summit and Bio€quity Europe.
Tell your story; find the right investors
Looking for investors or partners? Apply now to be considered for the BioCentury-BayHelix East-West Biopharma Summit or Bio€quity Europe Presenting Company Class. Presenting Companies can expect to receive significantly more 1x1 meeting requests than non-presenters.
BioCentury Sponsored Events
Marking the 31st edition of BioCentury’s “Back to School” report, BioCentury and Oppenheimer & Co. bring together a panel of experienced thought leaders to discuss the ingredients for creating and growing biotechs to the highest market cap tier, and how the fundamentals will play out in the industry following the market reset:
- How to pick your lead asset
- When is the right time to partner
- How to optimize around probability of success
- Where to fight for investor attention
- And much more.
Hosted by BioCentury & Oppenheimer
The drug price-setting provisions of the Inflation Reduction Act (IRA) will reconfigure the commercial landscape in the U.S., forcing biopharma companies and their investors to develop new strategies for R&D and business success.
Hosted by BioCentury & Putnam Associates
In this webinar, key opinion leaders from Owkin, Bristol-Myers Squibb and CancerLinQ gather to discuss how data-driven Covariate Adjustment improves clinical trials by increasing statistical power and widening eligibility criteria.
Hosted by BioCentury & Owkin
Industry KOL's discuss the current state of AI in oncology, and how building research networks in a privacy-preserving way is key for unlocking insights from the vast amount of patient data in hospitals and research centers to accelerate drug discovery.
Hosted by BioCentury & Owkin
Past Events
In 2023, BioCentury hits the road to organize three educational and networking events in Amsterdam, London, and Boston. Launching this series is an in-depth interview with Europe’s top Regulator.
Bio€quity Europe is the industry’s premier CEO and investor conference. Join the discussion in Dublin or attend from home via a digital pass. Plus take advantage of two bonus days of digital one-to-one meetings.
The world has changed: Emerging biopharmas in the U.S., Europe and Asia now face the same dilemma: How do you globalize to deliver innovation to patients and achieve an ROI for investors?
Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs – join the discussion in Milan or attend the full event via our digital platform, May 16-18, 2022.
Chinese biotechs and medtechs race across the Bridge to Innovation. The 8th BioCentury-BayHelix China Healthcare Summit showcases the China story, promising to have a lasting impact on the global biopharma industry.
Europe's premier international showcase for financial dealmakers and biopharma C-suite executives to meet rising biotechs.
BioCentury and BayHelix Present: The 7th China Healthcare Summit - Doubling Down on Innovation.
BioCentury and BayHelix Present: The 6th China Healthcare Summit - China In The World.
Bio€quity Europe transformed conferences with its turf-neutral approach, inviting finance, business development, and licensing experts to connect with curated Presenting Companies.
Bio€quity Europe is the seminal industry event for financial dealmakers looking for life science companies positioning themselves to attract capital, and for pharmaceutical professionals to assess prospects.
China's Globally Facing Future: The China Summit is the event for biopharma and life sciences executives and investors to see the innovation, business and policy transformations taking place in China.
Supported Industry Events
HealthTech Innovation Days (HTID®), initiated by France Biotech and implemented by the HealthTech For Care endowment fund, provides a forum for all stakeholders in the life sciences to meet and bring innovation to patients. Each year, HTID brings together over 800 participants in Paris. The 5th edition will take place on October 24 and 25, 2023 in Paris, and on October 27 in virtual form only.
Europe’s healthtech sector is growing and we are all facing the same challenges. At the HealthTech Investor Summit we bring together financers, entrepreneurs, mentors, experts and innovators. We will join forces and address today’s challeges while showcasing Europe’s finest healthtech innovations.
The HealthTech Investor Summit in Bruges, Belgium will be an essential event for investors and innovators alike. Join us and get connected, share or find new insights and last but not least, grow your innovations into market-ready products!